Latest filing published 22 Mar 2023 for Apyx Medical Corp, €60k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Craig A. Swandal, listed as board member, appears in our data through filings on Apyx Medical Corp shares, published by SEC (Form 4). The record holds 7 filings, for trades running from 10 January 2019 to 21 March 2022.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 22 March 2023, the filings show an option exercise worth €60k in Apyx Medical Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations